AAAAAA

   
Results: 1-6 |
Results: 6
Low-energy electron diffraction, X-ray photoelectron spectroscopy, and CO-temperature-programmed desorption characterization of bimetallic ruthenium-platinum surfaces prepared by chemical vapor deposition
Authors: Lamouri, A Gofer, Y Luo, Y Chottiner, GS Scherson, DA
Citation: A. Lamouri et al., Low-energy electron diffraction, X-ray photoelectron spectroscopy, and CO-temperature-programmed desorption characterization of bimetallic ruthenium-platinum surfaces prepared by chemical vapor deposition, J PHYS CH B, 105(26), 2001, pp. 6172-6177
PMS-601: a new PAF-receptor antagonist with antiretroviral and anti-inflammatory properties.
Authors: Martin, M Serradji, N Dereuddre-Bosquet, N Bensaid, O Fichet, G Lamouri, A Heymans, F Clayette, P Godfroid, JJ Dormont, D
Citation: M. Martin et al., PMS-601: a new PAF-receptor antagonist with antiretroviral and anti-inflammatory properties., PATH BIOL, 48(5), 2000, pp. 513-519
PMS-601, a new platelet-activating factor receptor antagonist that inhibits human immunodeficiency virus replication and potentiates zidovudine activity in macrophages
Authors: Martin, M Serradji, N Dereuddre-Bosquet, N Le Pavec, G Fichet, G Lamouri, A Heymans, F Godfroid, JJ Clayette, P Dormont, D
Citation: M. Martin et al., PMS-601, a new platelet-activating factor receptor antagonist that inhibits human immunodeficiency virus replication and potentiates zidovudine activity in macrophages, ANTIM AG CH, 44(11), 2000, pp. 3150-3154
Structure-activity relationships in platelet-activating factor (PAF). 10. From PAF antagonism to inhibition of HIV-1 replication
Authors: Serradji, N Bensaid, O Martin, M Kan, E Dereuddre-Bosquet, N Redeuilh, C Huet, J Heymans, F Lamouri, A Clayette, P Dong, CZ Dormont, D Godfroid, JJ
Citation: N. Serradji et al., Structure-activity relationships in platelet-activating factor (PAF). 10. From PAF antagonism to inhibition of HIV-1 replication, J MED CHEM, 43(11), 2000, pp. 2149-2154
Design and synthesis of imidazoline derivatives active on glucose homeostasis in a rat model of type II diabetes. 2. Syntheses and biological activities of 1,4-dialkyl-,1,4-dibenzyl, and 1-benzyl-4-alkyl-2-(4 ',5 '-dihydro-1' H-imidazol-2 '-yl)piperazines and isosteric analogues of imidazoline
Authors: Le Bihan, G Rondu, F Pele-Tounian, A Wang, X Lidy, S Touboul, E Lamouri, A Dive, G Huet, J Pfeiffer, B Renard, P Guardiola-Lemaitre, B Manechez, D Penicaud, L Ktorza, A Godfroid, JJ
Citation: G. Le Bihan et al., Design and synthesis of imidazoline derivatives active on glucose homeostasis in a rat model of type II diabetes. 2. Syntheses and biological activities of 1,4-dialkyl-,1,4-dibenzyl, and 1-benzyl-4-alkyl-2-(4 ',5 '-dihydro-1' H-imidazol-2 '-yl)piperazines and isosteric analogues of imidazoline, J MED CHEM, 42(9), 1999, pp. 1587-1603
Effect of the new imidazoline derivative S-22068 (PMS 847) on insulin secretion in vitro and glucose turnover in vivo in rats
Authors: Pele-Tounian, A Chan, SLF Rondu, F Le Bihan, G Giroix, MH Lamouri, A Touboul, E Pfeiffer, B Manechez, D Renard, P Guardiola-Lemaitre, B Godfroid, JJ Penicaud, L Morgan, NG Ktorza, A
Citation: A. Pele-tounian et al., Effect of the new imidazoline derivative S-22068 (PMS 847) on insulin secretion in vitro and glucose turnover in vivo in rats, EUR J PHARM, 377(1), 1999, pp. 81-87
Risultati: 1-6 |